MedPath
NMPA Approval

Blinatumomab for Injection

国药准字SJ20200026

Amgen Inc.

December 2, 2020

Drug Information

注射用贝林妥欧单抗

倍利妥

注射剂

35μg/瓶

生物制品

December 2, 2020

December 1, 2025

Company Information

Applicant Company

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320, United States of America

Manufacturing Company

Pottery Road, Dun Laoghaire,Dublin, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用贝林妥欧单抗 - NMPA 批准文号 | MedPath